Abstract
Abstract In this article, we discuss the interaction between the Covid-19 vaccine rollout in EU member states and the effective use of grants and soft loans from the EU pandemic recovery fund. With some of the national spending plans for the Recovery Fund still awaiting initial submission (Bulgaria), others pending the Commission’s endorsement (Poland, Hungary) or formal Council’s approval (Romania, Estonia), and various other national plans in their implementation stage, the next challenge for policymakers will be to ensure that the initial and subsequent tranches of EU funds are released as economies reopen. We claim that special attention ought to be paid to Central and Eastern Europe, where some countries are lagging in their vaccine rollout and/or the preparation for their use of the EU recovery funds. This is likely to be an important test for EU institutions in determining the stability and coherence of the European project as a whole.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
